Ladenburg Thalmann Financial Services’s Lipocine LPCN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$3K Buy
509
+118
+30% +$3.02K ﹤0.01% 4964
2019
Q3
$19K Hold
391
﹤0.01% 4070
2019
Q2
$13K Hold
391
﹤0.01% 4309
2019
Q1
$15K Hold
391
﹤0.01% 4173
2018
Q4
$9K Sell
391
-59
-13% -$1.37K ﹤0.01% 4345
2018
Q3
$11K Sell
450
-100
-18% -$2.46K ﹤0.01% 4239
2018
Q2
$14K Hold
550
﹤0.01% 4053
2018
Q1
$14K Sell
550
-65
-11% -$1.81K ﹤0.01% 4053
2017
Q4
$36K Sell
615
-22
-3% -$1.37K ﹤0.01% 3447
2017
Q3
$43K Buy
637
+59
+10% +$4.27K ﹤0.01% 3190
2017
Q2
$40K Buy
578
+36
+7% +$2.35K ﹤0.01% 3177
2017
Q1
$36K Buy
542
+100
+23% +$6.48K ﹤0.01% 3154
2016
Q4
$28K Hold
442
﹤0.01% 3256
2016
Q3
$34K Buy
442
+29
+7% +$1.8K ﹤0.01% 3062
2016
Q2
$21K Buy
413
+165
+67% +$25.6K ﹤0.01% 3307
2016
Q1
$43K Hold
248
﹤0.01% 2709
2015
Q4
$54K Hold
248
﹤0.01% 2498
2015
Q3
$50K Buy
248
+29
+13% +$6.71K ﹤0.01% 2471
2015
Q2
$32K Buy
219
+22
+11% +$2.73K ﹤0.01% 2900
2015
Q1
$23K Buy
197
+21
+12% +$2.28K ﹤0.01% 3094
2014
Q4
$16K Buy
176
+58
+49% +$4.9K ﹤0.01% 3139
2014
Q3
$12K Buy
118
+59
+100% +$7.33K ﹤0.01% 2986
2014
Q2
$6K Buy
+59
New +$7.06K ﹤0.01% 3309

Other funds holding LPCN

Ladenburg Thalmann Financial Services's LPCN Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its Lipocine (LPCN) stake by 30% in Q4 2019, buying an estimated $3.02K and bringing the position to 509 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #4964.

Ladenburg Thalmann Financial Services first reported a position in LPCN in Q2 2014 and has held it in 23 quarters since. The position peaked at $54K in Q4 2015. 32 funds tracked by Wall St. Rank hold LPCN as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 509 shares of Lipocine worth $3K as of Q4 2019.
  • Ladenburg Thalmann Financial Services bought 118 Lipocine shares in Q4 2019, an estimated $3.02K.
  • Lipocine made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4964 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Lipocine in Q2 2014 and has held it in 23 quarters since.
  • Ladenburg Thalmann Financial Services's Lipocine position peaked at $54K in Q4 2015.
  • 32 funds tracked by Wall St. Rank held Lipocine as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.